#International #Business @WeedConnection

Share This

New WC Franchise in Development @ RRP OG LLC
All Advertising/Media Services Will Be Honored
10-50% DiScOuNt :: Connect / Select You Plan

. . . .

Ask about our current promotion, which is a free listing with purchase of any other service @WeedConnection. Recently started rebuilding our global database and added a new/temp delivery section to our directory. Send us an email to submit any current information. Click here for listing and advertising information. The directory is a huge project that requires maintenance. We still have big plans for future development and production. Join(t) the team as a regional manager, college intern, street team member, or click here for a list of other open positions. Support, subscribe, follow, share, like, and mention growing cannabis business @WeedConnection


#iNTERNATiONAL #Directory

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube @WeedConnection @ Yelp @WeedConnection @ Google+ @WeedConnection @ instaGram

weedconnection.com

#NORML #News @WeedConnection

Share This

Recap of Top #Stories from Last Year; To be Topped in 2024?

#1: MORE STATES ENACT ADULT-USE MARIJUANA LEGALIZATION LAWS

Delaware, Minnesota, and Ohio enacted laws in 2023 legalizing adult-use marijuana possession and providing timelines for regulating retail cannabis markets. In addition, Maryland lawmakers passed legislation in May regulating adult-use marijuana sales. Those sales began on July 1st. In January, lawmakers in the US Virgin Islands also approved an adult-use legalization law, though its provisions have yet to take effect.

“For the first time since the adoption of federal marijuana prohibition, more US citizens reside in jurisdictions where cannabis is state-legal than live somewhere where it is not,” NORML Deputy Director Paul Armentano said.

#2: HHS RECOMMENDS DEA RECLASSIFY CANNABIS AS A SCHEDULE III SUBSTANCE

Bloomberg News reported in August that it had obtained a leaked letter from the Department of Health and Human Services (HHS) recommending that the US Drug Enforcement Administration reclassify cannabis from a Schedule I to a Schedule III controlled substance under federal law. The Biden Administration initiated the review last year.

The DEA, which has the final authority regarding drug scheduling under the Controlled Substances Act, has yet to publicly take any action on the matter.

NORML has criticized proposals calling for cannabis to be rescheduled from Schedule I to Schedule III, opining, “Rescheduling marijuana fails to provide states with the explicit legal authority to regulate it within their borders as they see fit, free from federal interference.” Rather, NORML calls for removing cannabis from the CSA altogether in a manner similar to alcohol.

#3: MORE AMERICANS THAN EVER SAY CANNABIS SHOULD BE LEGAL FOR ADULTS

A record 70 percent of US adults believe that “the use of marijuana should be legal,” according to nationwide polling data released in November by Gallup. That’s an increase of 19 percentage points since 2014, when Colorado and Washington became the first states to implement adult-use cannabis legalization, and the highest level of support ever reported by Gallup pollsters.

“There’s no ‘buyers’ remorse’ among the public when it comes to legalizing cannabis,” said NORML’s Political Director Morgan Fox. “As more states have adopted legalization, public support for this policy has risen dramatically. That’s because these policies are largely working as intended and because voters prefer legalization and regulation over the failed policy of marijuana prohibition.”

Other polling conducted by Gallup in 2023 determined that most US adults believe that marijuana use poses fewer risks to health than does either the use of alcohol or cigarettes, and that half of all Americans ages 18 and older have tried cannabis.

#4 MORE STATES ENACT WORKPLACE PROTECTIONS FOR CANNABIS CONSUMERS

Michigan and Washington adopted legislation in 2023 halting public employers from engaging in pre-employment marijuana testing for those applying to non-safety-sensitive positions. Several other states and municipalities have adopted similar measures. California, Connecticut, the District of Columbia, Minnesota, Montana, New Jersey, New York, and Rhode Island have enacted broader workplace protection laws limiting employers’ ability to conduct on-the-job testing for marijuana metabolites or to sanction employees for their consumption of cannabis while off the job.

“These decisions reflect today’s changing cultural and legal landscape surrounding cannabis,” NORML’s Deputy Director Paul Armentano said. “It is time for workplace policies to adapt to this new reality and to cease punishing employees for activities they engage in during their off-hours that pose no legitimate threat to either workplace safety or productivity.”

#5: FEDERAL COURTS REJECT SECOND AMENDMENT BAN FOR MARIJUANA CONSUMERS

In August, judges with the 5th U.S. Circuit Court of Appeals ruled that a 1968 federal law prohibiting the possession or sale of a firearm to an “unlawful user” of a controlled substance should not be applied so broadly that it would criminalize all gun owners with a history of marijuana use. NORML Legal Committee members filed an amicus (aka friend of the court) brief, calling on the court to find the ban unconstitutional.

The decision came months after a federal judge for the US District Court for the Western District of Oklahoma similarly ruled that the “mere status as a user of marijuana” does not justify the federal government “stripping [the defendant] of his fundamental right to possess a firearm.” A judge for the U.S. District Court for the Western District of Texas also issued a similar decision in April.

NORML lawyers have also filed a similar amicus brief in another Second Amendment case in the 11th Circuit Court of Appeals.

#6: MARIJUANA ARRESTS FALL TO 30-YEAR LOW

State and local police made at least 227,108 arrests for marijuana violations last year, according to data compiled by the FBI’s Crime Data Explorer. Not since the early 1990s has the FBI reported so few annual marijuana-related arrests.

Marijuana arrests peaked in the United States in 2007, when police made over 870,000 marijuana-related arrests. At that time, just under half (48 percent) of all drug-related arrests in the US were for marijuana-related violations.

#7: POTUS ISSUES PARDON PROCLAMATION FOR THOSE WITH MARIJUANA-RELATED CONVICTIONS

President Joe Biden issued a directive in December expanding the pool of marijuana offenders eligible for federal pardons. “I am issuing a Proclamation that will pardon additional offenses of simple possession and use of marijuana under federal and D.C. law,” the President stated. “Criminal records for marijuana use and possession have imposed needless barriers to employment, housing, and educational opportunities. Too many lives have been upended because of our failed approach to marijuana. It’s time that we right these wrongs.”

The President issued a similar pardon proclamation last October, and in March the Justice Department opened an online portal for eligible applicants to apply for pardon certificates. Estimates provided at that time by the US Sentencing Commission suggested that nearly 7,000 Americans with low-level federal marijuana-related convictions would be eligible for relief under the directive.

It is not yet clear how many additional citizens with federal records will be eligible for relief under the President’s latest proclamation. NORML had called upon the Administration to grant blanket pardon relief to nonviolent marijuana offenders shortly after the President took office.

#8 TEEN MARIJUANA USE REMAINS BELOW PRE-PANDEMIC LEVELS

Federally funded surveys by the University of Michigan and by the Substance Abuse Mental Health Services Administration report that rates of teens’ marijuana use are below pre-pandemic levels and near historic lows. The surveys are among the latest to affirm that the adoption of statewide adult-use legalization laws is not linked to any uptick in cannabis use by young people.

“These findings ought to reassure lawmakers and the public that cannabis access for adults can be legally regulated in a manner that is safe, effective, and that does not significantly impact young people’s consumption habits,” NORML’s Deputy Director Paul Armentano said.

#9: FDA FAILS TO ESTABLISH RULES FOR HEMP-DERIVED CANNABIS PRODUCTS

Representatives of the US Food and Drug Administration announced in February that they were abandoning efforts to craft regulations governing the production and sale of hemp-derived products containing high levels of CBD and other cannabinoids. Instead, the agency called upon Congress to address the issue. The FDA had studied the issue for five years before determining that the agency’s existing rules governing foods and dietary supplements are inadequate for addressing hemp-derived products.

For years, NORML and other groups have urged the FDA to establish regulatory guidelines governing the production, testing, labeling, and marketing of hemp-derived cannabinoid products. Analyses conducted by the FDA and others have consistently reported that many of these over-the-counter products are of variable quality and potency and may contain contaminants, adulterants, or elevated levels of heavy metals.

#10: KENTUCKY BECOMES 38TH STATE TO LEGALIZE MEDICAL CANNABIS ACCESS

Democratic Gov. Andy Beshear signed legislation in March directing the state’s Cabinet for Health and Family Services to implement a comprehensive medical cannabis access program. The program is expected to be operational on January 1, 2025.

“For years, Kentuckians have been calling for medical cannabis legalization and now they will have the freedom to safely access regulated, therapeutic products right here at home,” said Matthew Bratcher, Executive Director of Kentucky NORML. “While there is still work to be done, this is a historic first step and we look forward to continuing our work representing Kentucky patients.”

#NORML #News @WeedConnection

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube

 

#NORML #News @WeedConnection

Share This

Survey: Athletes Report Using Cannabis Products To Promote Exercise Recovery

Kent, OH: Those who engage in regular exercise frequently report consuming cannabis products to assist in recovering from physical activity, according to data published in the Journal of Cannabis Research.

Researchers affiliated with Kent State University in Ohio surveyed over 100 subjects who reported using cannabis and regularly engaging in aerobic and/or resistance exercise.

Investigators summarized their findings as follows: “Twenty-two participants (20 percent) reported using CBD for recovery from aerobic exercise and 25 participants (23 percent) reported CBD use to recover from resistance exercise. Sixty-eight participants (61 percent) reported using THC after aerobic exercise for recovery. Similarly, 67 participants (60 percent) reported using THC after resistance exercise for recovery. When participants were asked, ‘Do you feel that cannabis in the form of CBD aids in your recovery?’ 93 percent stated ‘yes’ while seven percent stated, ‘I’m not sure.’ When asked, ‘Do you feel that THC aids in your recovery?’, 87 percent of participants stated, ‘yes’ while 13 percent stated, ‘I’m not sure’. No participant answered, ‘no’, for either of these questions. All of the participants felt that use of cannabis was low risk regarding health outcomes.”

The authors concluded: “The present study demonstrated that in addition to more traditional recovery methods, cannabis is used as an ergogenic recovery aid by individuals that exercise regularly. … More data are necessary to understand the role of cannabis in exercise recovery as well as perceived ergogenic benefits of cannabis by individuals who both regularly participate in exercise and habitually use cannabis.”

Another study published in the same journal earlier this year reported that the twice-daily use of topical CBD alleviates chronic pain in former elite-level (professional) athletes.

Several other studies have found that cannabis use is associated with increased exercise frequency, including among older adults. Yet another study, published in July, found that subjects reported “a more positive exercise experience” when they ran immediately after having used cannabis compared to when they did not.

Full text of the study, “Cannabis use for exercise recovery in trained individuals: A survey study,” appears in the Journal of Cannabis Research.

Study: Cannabis Oil Extracts Associated With Sustained Improvements in Patients With Chronic Health Conditions

Sydney, Australia: The use of plant-derived cannabis extracts is associated with health-related quality of life improvements in patients suffering from pain, fatigue, and other chronic conditions, according to observational trial data published in the journal PLOS One.

Australian investigators assessed the efficacy of cannabinoid extracts in a cohort of 2,300+ patients authorized to use medical cannabis. (Under Australian law, physicians may authorize cannabis products to patients unresponsive to conventional prescription treatments.) Study participants consumed extracts containing varying percentages of THC and CBD for three months.

Consistent with the results of other large-scale observational studies, researchers reported clinically meaningful improvements following cannabis treatment.

“This study found [that] overall HRQL [health-related quality of life] improved over 3-months in patients accessing prescribed MC [medicinal cannabis] in Australia,” authors reported. “Results showed both statistically significant and clinically meaningful improvements in overall HRQL and fatigue for people with chronic health conditions. Similar improvements were found in pain scores for participants with chronic pain; depression scores for patients with depression; and anxiety scores in patients with anxiety.”

They concluded: “Our findings suggest that prescribing MC in clinical practice may alleviate symptoms of pain, fatigue, anxiety, and depression in patients with chronic health conditions and improve overall HRQL. ... The findings from this study contribute to the ongoing evidence for decision making both in clinical practice and at policy level.”

Full text of the study, “Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study,” appears in PLOS One.

Pilot Study: Vaporized Cannabis Associated With Reduced Symptoms in Patients With Post-Traumatic Stress

Vancouver, Canada: The short-term use of herbal cannabis consisting of a balanced ratio of THC and CBD is associated with symptom reductions in patients with post-traumatic stress, according to data published in the journal Trials.

Canadian researchers assessed subjects’ use of vaporized cannabis over a three-week period.

Investigators reported, “Comparison of CAPS [Clinician Administered PTSD Scale] scores pre and post treatment identified a trend toward reduction in PTSD symptoms. ... However, under-recruitment resulted in low power and prohibited placebo comparison, making these results more suggestive than persuasive.”

They concluded, “Positive trending results and high patient need mandate future studies of cannabis for the treatment of PTSD.”

Two recent observational studies, one from Australia and the other from the United Kingdom, reported that patients diagnosed with post-traumatic stress respond favorably to medical cannabis treatment. By contrast, a 2021 clinical trial reported that the inhalation of marijuana flowers provided limited benefits compared to placebo in treating symptoms of PTSD.

Full text of the study, “A small clinical trial of vaporized cannabis for PTSD: Suggestive results and directions for future study,” appears in Trials.

Survey: Many Canadian Nurses Don’t Receive Any Training on the Use of Medical Cannabis

Winnipeg, Canada: Fewer than four in ten Canadian nursing students say that they receive information about the use of medical cannabis during their training, according to survey data published in the journal Nurse Education Today.

Over three hundred nursing students participated in the survey. Only 38 percent acknowledged “receiving any education on cannabis in their nursing program.” Over 90 percent of respondents acknowledged that they would feel uncomfortable discussing cannabis with their patients without further educational training.

“Education on both medical and non-medical cannabis is needed to support future nurses addressing cannabis use in their clinical practice,” the study’s authors concluded. “Nursing institutions must implement and evaluate curricula to ensure nursing students are adequately prepared to address cannabis use in their clinical practice and their own fitness to practice.”

Cannabis has been legally available in Canada via a doctor’s authorization since 2001. The Canadian government legalized marijuana products for adults in 2018.

The study’s findings are consistent with those of prior surveys of health professionals in Canada and the United States which report that most doctors and nurses believe that they receive insufficient training with regard to cannabis.

Full text of the study, “Baccalaureate nursing students’ knowledge, attitudes, educational needs, and use of medical and non-medical cannabis at five institutions in Manitoba, Canada: A cross-sectional analysis,” appears in Nurse Education Today.

#NORML #News @WeedConnection

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube

#FollowFriday @RussellRope #OG @WeedConnection

Share This
* New Show NQ @TheTrueOGReport *

* READ & Click & READ & Click *

:: Creator @ WC @ RR Productions ::
:: Follow @RussellRope For Updates ::

#OG @RussellRope #Creator @WeedConnection

:: Join The Revolution ::
:: Read & Take Action ::
:: True OG Stories @ RR ::
:: SUPREME #LegalTrillOG ::

----------------------------------

:: Media Marketing Services @ RRP ::

:: Connect | ADVERTISE | Work | Submit ::

:: Subscribe | Follow | Share | Like | Support ::

:: #FreeTheWeed @WeedConnection ::

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube @WeedConnection @ Yelp @WeedConnection @ Google+ @WeedConnection @ instaGram

weedconnection.com

#SocialMedia #Revolution @WeedConnection

Share This

* Connect @RussellRope *
* New WC Social Links List NQ *

:: FYi FB/iG Terminated WC Accts Again ::
:: No Just Cause FB iS Run By Sociopaths ::
:: They iNvested iN Criminal Competition ::

:: See Fed RiCO Lawsuit @ RR ::

. . . .

:: Join Us For A Hollyweed Sesh ::
:: Subscribe, Follow, Like, Add, Share ::

@WeedCONNECTiON

#SocialMedia @WeedConnection

SOCIAL:
twitter.com/weedconnection
instagram.com/weedconnection
facebook.com/weedconnection
myspace.com/weedconnection420
youtube.com/weedconnection420

BUSINESS:
weedconnection.com
weedconnection.com/advertise

CREATOR:
@RussellRope @ russellrope.com/blog

#Support Your #OG(s)
#LinkUP @WeedConnection

@WeedConnection .com



Email:

#FreeTheOG
#FreeTheWeed
Fund WC++

Read RR True Story
Connect | ADVERTISE | Work | Submit
Subscribe | Follow | Share | Like | Support

WeedConnection @ Twitter @WeedConnection @ Facebook @WeedConnection @ LinkedIn @WeedConnection @ Foursquare @WeedConnection @ Spotify @WeedConnection @ YouTube @WeedConnection @ Yelp @WeedConnection @ Google+ @WeedConnection @ instaGram

weedconnection.com